dc.contributor.author | Gül, Ahmet | |
dc.contributor.author | Öztürk, Recep | |
dc.date.accessioned | 2023-01-02T08:31:18Z | |
dc.date.available | 2023-01-02T08:31:18Z | |
dc.date.issued | 2022 | en_US |
dc.identifier.citation | Gül, A. ve Öztürk, R. (2022). Immune response against viral infections and nucleic acid-based vaccines. Scandinavian Journal of Immunology, 96(6). https://doi.org/10.1111/sji.13221 | en_US |
dc.identifier.issn | 0300-9475 | |
dc.identifier.issn | 1365-3083 | |
dc.identifier.uri | https://doi.org/10.1111/sji.13221 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/10220 | |
dc.description.abstract | To the editor,We read with interest the letter by Polykretis,1 which sum-marized some basic immunological principles in relation to COVID- 19 vaccines. However, the terminologies the author uses to describe the types of vaccines and targets of immune response are in our view misinforming and have basic errors. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
dc.subject | Autoimmunity | en_US |
dc.subject | Biodistribution | en_US |
dc.subject | mRNA | en_US |
dc.subject | Nucleic Acid-Based Vaccines | en_US |
dc.subject | Vaccine | en_US |
dc.subject | Viral Infection | en_US |
dc.title | Immune response against viral infections and nucleic acid-based vaccines | en_US |
dc.type | letter | en_US |
dc.relation.ispartof | Scandinavian Journal of Immunology | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı | en_US |
dc.authorid | 0000-0002-2623-7212 | en_US |
dc.identifier.volume | 96 | en_US |
dc.identifier.issue | 6 | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.doi | 10.1111/sji.13221 | en_US |
dc.institutionauthor | Öztürk, Recep | |
dc.identifier.wosquality | Q3 | en_US |
dc.identifier.wos | 000867458500001 | en_US |
dc.identifier.scopus | 2-s2.0-85139778076 | en_US |
dc.identifier.pmid | 36300515 | en_US |
dc.identifier.scopusquality | Q2 | en_US |